Timothy N Clinton
Overview
Explore the profile of Timothy N Clinton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
239
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ikhapoh I, Atairu U, Reich A, Mantia C, Wei X, Sekar R, et al.
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941550
: Comprehending the patient composition of bladder cancer (BC) clinical trials is crucial for effectively designing clinical trials and contextualizing the generated science. In this study, we reviewed publicly available...
2.
Antonelli L, Heidenreich A, Bagrodia A, Amini A, Baky F, Branger N, et al.
BJU Int
. 2024 Dec;
PMID: 39662898
Objectives: To reassess the role of primary retroperitoneal lymph node dissection (RPLND) in patients with marker-negative non-seminomatous germ cell tumour (NSGCT) clinical stage (CS) 2a, to explore results in patients...
3.
Kim K, Alam S, Kuo F, Chen Z, Yip W, Katims A, et al.
Eur Urol
. 2024 Nov;
87(3):342-354.
PMID: 39550333
Background And Objective: Molecular classification of upper tract urothelial carcinoma (UTUC) can provide insight into divergent clinical outcomes and provide a biological rationale for clinical decision-making. As such, we performed...
4.
DAndrea V, Magnani C, Ernandez J, Bellmunt J, Mossanen M, Clinton T, et al.
Curr Urol Rep
. 2024 Oct;
26(1):12.
PMID: 39382743
Purpose Of Review: This review explores the current landscape of treatments which target the DNA damage response (DDR) in metastatic and muscle-invasive bladder cancer. It emphasizes recent clinical trials which...
5.
OConnell K, Thomas J, Murad F, Zhou G, Sonpavde G, Mossanen M, et al.
J Eur Acad Dermatol Venereol
. 2024 Jun;
39(3):576-585.
PMID: 38842227
Background: Penile squamous cell carcinoma (PSCC) carries significant morbidity and mortality. Literature is limited regarding prognostic factors, especially prognostic factors for development of metastasis. Objectives: To identify independent prognostic factors...
6.
Lenis A, Whiting K, Ravichandran V, Tallman J, Alam S, Chu C, et al.
JCO Precis Oncol
. 2024 May;
8:e2300274.
PMID: 38691813
Purpose: Patients with residual invasive bladder cancer after neoadjuvant chemotherapy (NAC) and radical cystectomy have a poor prognosis. Data on adjuvant therapy for these patients are conflicting. We sought to...
7.
Beatrici E, Labban M, Filipas D, Stone B, Reis L, Dagnino F, et al.
Int Braz J Urol
. 2024 Feb;
50(2):199-208.
PMID: 38386790
Purpose: Smoking is a recognized risk factor for bladder BC and lung cancer LC. We investigated the enduring risk of BC after smoking cessation using U.S. national survey data. Our...
8.
Yip W, Assel M, Wong N, Tracey A, Alvim R, Nogueira L, et al.
Urol Pract
. 2024 Feb;
11(2):356-366.
PMID: 38315829
Introduction: We evaluated surgical trends, perioperative management evolution, and oncologic outcomes in patients who underwent radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) at a tertiary cancer center over...
9.
DAndrea V, Qian Z, Yim K, Egan J, Magnani C, Feldman A, et al.
Urol Oncol
. 2023 Nov;
41(12):489.e1-489.e6.
PMID: 37980224
Introduction: Retroperitoneal lymph node dissection (RPLND) is the standard of care for testicular cancer in various disease settings. Deep vein thrombosis (DVT) complications have been reported to occur in <1%...
10.
DAndrea V, Melnick K, Yim K, Ernandez J, Onochie N, Clinton T, et al.
J Clin Med
. 2023 Nov;
12(21).
PMID: 37959309
Radical cystectomy (RC) is an integral part of the management of patients with advanced-stage bladder cancer. This major oncologic operation is prone to complications resulting in morbidity and mortality. We...